Amicar and Mi - a phase IV clinical study of FDA data

Summary:

Mi is reported as a side effect among people who take Amicar (aminocaproic acid), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Lovenox, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Mi when taking Amicar. It is created by eHealthMe based on reports of 1,317 people who have side effects when taking Amicar from the FDA, and is updated regularly.

What is Amicar?

Amicar has active ingredients of aminocaproic acid. eHealthMe is studying from 1,323 Amicar users. Check the latest studies of Amicar.

What is Mi?

Mi (myocardial infarction, heart attack) is found to be associated with 3,358 drugs and 3,267 conditions by eHealthMe. Check the latest studies of Mi.

On Apr, 09, 2026

1,317 people reported to have side effects when taking Amicar.
Among them, 47 people (3.57%) have Mi.

Among these 47 people:

How long have people been on Amicar when they have Mi? *

What is the gender of people who have Mi when taking Amicar? *

female: 6.67 %
male: 93.33 %

What is the age of people who have Mi when taking Amicar? *

What are other drugs people take besides Amicar? *

What are other side effects people have besides Mi? *

Pain: 31 people, 65.96%
Stress And Anxiety: 30 people, 63.83%
Emotional Distress: 28 people, 59.57%
Injury: 28 people, 59.57%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 20 people, 42.55%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 18 people, 38.30%
Anaemia (lack of blood): 16 people, 34.04%
Rashes (redness): 14 people, 29.79%
Joint Pain: 14 people, 29.79%
Gingival Ulceration (ulcer on gums): 13 people, 27.66%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 27.66%
Pain: 7 people, 14.89%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 3 people, 6.38%
Postoperative Wound Infection: 2 people, 4.26%
Mediastinal Haemorrhage (bleeding in mediastinum): 2 people, 4.26%
Diabetes: 2 people, 4.26%
Headache (pain in head): 2 people, 4.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.13%
Cardiac Failure Congestive: 1 person, 2.13%
Cardiomyopathy (weakening of the heart muscle): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Amicar and have Mi?

- Check whether Mi is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amicar:

Amicar (1,323 reports)

Mi treatments and more:

Mi (266,142 reports)

Browse all side effects of Amicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mi:

Mi (3,358 drugs)

Browse all the conditions that are associated with Mi:

Mi (3,267 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aminocaproic acid (the active ingredients of Amicar) and Amicar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.